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Introduction
Sarcoidosis is a granulomatous lung disease 
that predisposes individuals to pulmonary 
pathogens. Patients with sarcoidosis Stages 
II-IV, and those with fibrocystic changes, are 
at an increased risk for aspergillus infection. 
Chronic pulmonary aspergillosis (CPA) can 
complicate late-stage sarcoidosis, leading to 
necrotizing granulomas, hemoptysis, and 
potentially disseminated infection.
Case Report
A 37-year-old male with multiple exposures 
presented with dyspnea, fever, and cough 
productive of blood-streaked sputum for 5 
months. Symptoms initially resolved with 
levofloxacin, but later recurred and then 
progressed. Imaging revealed bilateral  
middle and lower lobe cavitary lung  
lesions with fibrosis. 
Figure 2. Bilateral cavitary lung lesions 
with surrounding fibrosis, atelectasis, 
and bronchiectasis.
Figure 1. Bilateral pulmonary infiltrates 
and cavitary lesions on plain film.
Pulmonary function tests revealed a 
moderately-severe obstructive deficit.
SPIROMETRY Pred ULN LLN Actual % Pred
FVC (L) 4.59 5.5 3.69 *2.50 *54
FEV1 (L) 3.75 4.48 2.99 *1.66 *44
FEV1/FVC (%) 82 92 72 *66 *81
FEV6 (L) 4.57 5.38 3.76 *2.43 *53
FEV1/FEV6 (%) 82 90 74 *68 *83
FEF 25-75% (L/sec) 3.79 5.74 2.24 *0.87 *22
FEF Max (L/sec) 9.33 11.39 7.27 *5.00 *53
Expiratory Time (sec) 8.65
LUNG VOLUMES
TLC (Pleth) (L) 6.12 7.7 4.54 *4.08 *66
SVC (L) 4.59 5.5 3.69 *2.48 *54
TGV (L) 2.97 4.41 1.53 2.31 77
ERV (L) 1.44 0.71 49
RV (Pleth) (L) 1.57 2.31 0.83 1.59 101
RV/TLC (Pleth) (%) 26 34 18 *39 *150
Figure 3. PFT’s reveal moderately-severe obstructive defect with decreased diffusion 
capacity. A moderate restrictive defect is also present.
Two sputum fungal cultures grew Aspergillus 
niger. Extensive serum testing including ANA, 
ANCA, B-D-glucan, galactomannan, AFB/
quantiferon gold, cryptococcal antigen, and a 
fungal antibody panel were negative. EBUS 
transbronchial fine needle aspiration of node 
station 11L and transbronchial biopsy with 
bronchoalveolar lavage (BAL) of the left lower 
lobe was performed. Node station 11L 
revealed necrotizing granulomatous disease. 
Bronchial fungal cultures, aspergillus antigen 
and PJP were negative. Flow cytometry 
samples were unremarkable. The patient  
was treated with 4 months of voriconazole 
and a prolonged steroid taper. Repeat 
bronchoscopy revealed multiple necrotizing 
and non-necrotizing granulomas in the right 
upper lobe. All cultures were again negative. 
Surgical right lower lobe wedge resection 
demonstrated multiple non-necrotizing 
granulomas that coalesced primarily along 
the bronchovesicular bundles with prominent 
fibrosis, suspicious for sarcoidosis. The 
patient was then started on steroids and 
trimethoprim-sulfamethoxazole, and then 
maintained on hydroxychloroquine.
Discussion
CPA is a serious complication of sarcoidosis 
that is associated with poor outcomes. Up  
to 10% of patients with sarcoidosis develop 
aspergillus infections. CPA should be 
suspected in all patients with known lung 
disease who have cavitary lung lesions for at 
least three months, with direct evidence of 
aspergillus infection. Over 50% of patients 
have no visible aspergilloma on imaging.  
If left unchecked, CPA can progress into 
chronic fibrosing pulmonary aspergillosis.  
The mechanism of injury is possibly due to 
alveolar macrophage-induced free radical 
damage. Laboratory testing often reveals 
elevated serum aspergillus IgG levels; 
however, the most definitive evidence is 
positive direct microscopy or fungal cultures 
from BAL. Patients often require lifelong 
antifungal therapy, and extensive steroids. 
Conclusion
This case highlights the importance of early 
detection of aspergillus infections in patients 
with known pulmonary disease, particularly 
sarcoidosis. Early recognition and intervention 
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